CorMedix (NASDAQ:CRMD) Upgraded at StockNews.com
StockNews.com upgraded shares of CorMedix (NASDAQ:CRMD – Free Report) from a sell rating to a hold rating in a research note released on Tuesday. Several other equities analysts have also issued reports on CRMD. Needham & Company LLC reduced their target price on CorMedix from $18.00 to $12.00 and set a “buy” rating for the […]
StockNews.com upgraded shares of CorMedix (NASDAQ:CRMD – Free Report) from a sell rating to a hold rating in a research note released on Tuesday. Several other equities analysts have also issued reports on CRMD. Needham & Company LLC reduced their target price on CorMedix from $18.00 to $12.00 and set a “buy” rating for the […]
